InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,352.96
(
-0.02%
)
US TECH 100
18,545.20
(
0.02%
)
Dow Jones
38,886.17
(
0.20%
)
Brent Oil
79.85
(
-0.04%
)
Bitcoin
70,731.64
(
-0.05%
)
Post# of 689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor100

Send PM Follow Ignore
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Investor100

Re: Investor100 post# 569

Sunday, 05/24/2015 10:17:21 PM

Sunday, May 24, 2015 10:17:21 PM

Post# of 689
Transactions @ HZNP

Looking forward to the second half of 2015!

On Friday's call with analysts, Chief Business Officer Robert Carey said Horizon still has $500 million it could spend on acquisitions. "We've got sufficient capacity to execute on our plan right now and hope to continue to be active in the marketplace."

http://news.investors.com/050815-751719-hznp-raises-guidance-after-hptx-buyout.htm?ven=yahoocp&src=aurlled&ven=yahoo

Horizon Pharma plc Completes Hyperion Therapeutics Acquisition

Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID(R) 2% From Nuvo Research Inc.

Horizon Pharma completes acquisition of Vidara Therapeutics International LTD

Horizon Pharma announces definitive agreement to acquire Vidara Therapeutics International LTD

Horizon Pharma announces agreement to acquire U.S. rights to VIMOVO

Horizon Therapeutics completes merger with Nitec Pharma

http://www.horizonpharma.com/transactions/

Investor 100
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up